Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nephroblastic neoplasms.

Joseph D Khoury1

  • 1Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. joseph.khoury@stjude.org

Clinics in Laboratory Medicine
|April 26, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The WHO Classification of Genetic Tumour Syndromes: Considerations for Genetics.

Clinical genetics·2026
Same author

Clinicopathologic features of systemic ALK-negative anaplastic large cell lymphoma with TP53 deletion.

American journal of clinical pathology·2026
Same author

Practical approaches to the diagnosis and differential diagnosis of T-lymphoblastic leukemia/lymphoma.

Human pathology·2026
Same author

Genetic Profile, Treatment Response, and Outcomes of BCR::ABL1-Positive Mixed-Phenotype Acute Leukemia: A Study From the BCR::ABL1 Pathology Group.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

World Health Organization classification of tumours of the breast 6th edition 2026.

Histopathology·2026
Same author

Primary Cutaneous Gamma-Delta T-Cell Lymphoma With Aberrant CD20 Expression: Answer.

The American Journal of dermatopathology·2026
Same journal

Advances in Hemostasis Laboratory Testing.

Clinics in laboratory medicine·2026
Same journal

Extracellular Vesicles in Hemostasis.

Clinics in laboratory medicine·2026
Same journal

Thrombin Generation Assay: Ready for Prime Time.

Clinics in laboratory medicine·2026
Same journal

Viscoelastic Testing for the Laboratorian: Recent Advances and Practical Advice.

Clinics in laboratory medicine·2026
Same journal

Practical Recommendations for Harmonization of Hemostasis Testing Across Hospital Sites.

Clinics in laboratory medicine·2026
Same journal

The Role of Hypoxia in Vascular Endothelial Dysfunction and Venous Thromboembolism.

Clinics in laboratory medicine·2026
See all related articles

Nephroblastoma, also known as Wilms tumor, is a kidney cancer originating from immature cells. Its complex development involves genetic changes and varied cell types, impacting prognosis.

Area of Science:

  • Pediatric Oncology
  • Renal Embryogenesis
  • Cancer Genetics

Background:

  • Nephroblastoma (Wilms tumor) is a malignant embryonal neoplasm arising from nephrogenic blastemal cells.
  • Its development involves complex pathogenesis linked to genomic alterations at loci like WT1, WT2, FWT1, and FWT2.
  • Histologically, it comprises variable proportions of blastema, epithelium, and stroma, with diverse morphologic variations.

Purpose of the Study:

  • To discuss the pathogenesis and histologic assessment of nephroblastoma.
  • To highlight the prognostic and therapeutic significance of distinguishing favorable histology from anaplastic tumors.
  • To cover nephrogenic rests and cystic partially differentiated nephroblastoma variants.

Main Methods:

  • Histologic assessment of tumor morphology.

Related Experiment Videos

  • Review of pathogenetic mechanisms involving genomic alterations.
  • Discussion of specific nephroblastoma variants.

    • Main Results:

    • Nephroblastoma exhibits variable recapitulation of renal embryogenesis.
    • Genetic alterations in specific loci are associated with its pathogenesis.
    • Histologic classification, particularly distinguishing favorable histology from anaplasia, is crucial.

    Conclusions:

    • Accurate histologic assessment is vital for managing nephroblastoma.
    • Understanding the diverse histologic components and variants aids in diagnosis and treatment planning.
    • Further research into the genetic underpinnings can refine therapeutic strategies.